MétaCan
Menu
Back to cohort
Record W4384570568 · doi:10.5114/fpn.2023.127423

Lumateperone in the treatment of psychiatric disorders – a review of the literature

2023· review· en· W4384570568 on OpenAlexaboutno aff
Ada Kaczmarek, Wiktor Szymajda, Katarzyna Dettlaff

Bibliographic record

VenuePharmacotherapy in Psychiatry and Neurology · 2023
Typereview
Languageen
FieldMedicine
TopicBipolar Disorder and Treatment
Canadian institutionsnot available
Fundersnot available
KeywordsPharmacotherapyNeurologyPsychiatryMedicine

Abstract

fetched live from OpenAlex

Drug Administration) for the treatment of patients with schizophrenia and depressive episodes associated with bipolar disorder in 2019.Literature review.The review includes up-to-date publications concerning the efficacy of lumateperone in the treatment of psychiatric disorders -schizophrenia, bipolar disorder, but also insomnia, and dementia.The pharmacokinetic and pharmacodynamic characteristics of lumateperone and its precise mechanism of action were presented.The adverse reactions and possible drug interactions were likewise discussed.Conclusions.Lumateperone is a medication with an interesting mechanism of action, which is unique compared to other antipsychotic drugs.The analysis of clinical trials suggests that lumateperone is an effective and safe medication for the treatment of schizophrenia, as well as bipolar affective disorder.There are high hopes for the use of lumateperone in the treatment of insomnia and dementia. StreSzczenieCel. Terapia schorzeń psychiatrycznych, w tym schizofrenii i choroby afektywnej dwubiegunowej, ciągle się zmienia.Pojawiają się nowe substancje, które sprawiają, że leczenie wiąże się z mniejszą liczbą działań niepożądanych i wykorzystuje nowe mechanizmy działania.Celem artykułu jest przedstawienie właściwości, mechanizmu działania, zastosowania, ale i bezpieczeństwa lumateperonu -leku zaliczanego do substancji o działaniu AbStrAct Objectives.The treatment of psychiatric disorders, including schizophrenia and bipolar disorder, is constantly changing.There are new medications that reduce treatment-related side effects and present new mechanisms of action.This article aims to describe characteristics, mechanism of action, and medical use, but also the safety of lumateperone -a drug classified as antipsychotic medication, which was approved by the FDA (Food and Review article / Artykuł poglądowy Lumateperone in the treatment of psychiatric disorders -a review of the literatureLumateperon w leczeniu schorzeń psychiatrycznych -przegląd literatury

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Systematic review · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.004
Threshold uncertainty score0.013

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.001
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0020.001
Bibliometrics0.0030.003
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0040.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.029
GPT teacher head0.376
Teacher spread0.347 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designSystematic review
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations2
Published2023
Admission routes1
Has abstractyes

Explore more

Same venuePharmacotherapy in Psychiatry and NeurologySame topicBipolar Disorder and TreatmentFrench-language works237,207